No. Current evidence does not establish that vitamin K2 removes existing calcium deposits from arteries or reverses coronary atherosclerosis. Vitamin K is important for normal blood clotting, bone metabolism and the activation of proteins involved in vascular mineral regulation. Some recent randomized trials suggest that vitamin K2 supplementation, alone or combined with vitamin D3, may slow the progression of coronary artery calcification in selected patients. However, slowing further calcium accumulation is not the same as removing calcium already present, reopening narrowed arteries or preventing heart attacks. The 2026 DANCODE trial reported significantly slower coronary calcium-score progression over two years in patients receiving vitamin K2 and D3, but calcium scores increased in both treatment and placebo groups. These findings are promising, yet further research is needed to determine whether the observed changes improve clinical cardiovascular outcomes. The strongest established approach to arterial health remains sustained management of LDL cholesterol, blood pressure, blood sugar, smoking and other cardiovascular risk factors.

Vitamin K2 has attracted considerable attention because of its relationship with calcium metabolism. It is often promoted as a nutrient that directs calcium into bones and away from arteries, suggesting that supplementation might prevent or even reverse arterial calcification.

There is a legitimate biological foundation behind some of this interest. Vitamin K is needed to activate certain proteins, including matrix Gla protein, that participate in regulating mineral deposition in tissues.

However, the human body does not simply transport calcium from clogged arteries back into the bones when more K2 is consumed.

Arterial calcification develops through complex biological processes involving vascular cells, inflammation, lipid accumulation, kidney function and changes within atherosclerotic plaques. Once a calcified deposit has formed, its behavior cannot be predicted solely from vitamin K intake.

Recent studies make this subject more interesting, not less. The 2024 Danish trial reported a possible benefit in patients with more advanced baseline calcification, while the 2026 DANCODE trial demonstrated significantly slower calcium-score progression in people with severe coronary calcium deposits.

Another randomized study published in 2026 found slower progression of coronary calcium with menaquinone-7 supplementation in patients with symptomatic coronary disease.

These findings deserve careful attention, but none establishes that vitamin K2 dissolves existing arterial calcium or prevents heart attacks.

The useful question is not whether vitamin K2 can cleanse arteries. It is whether adequate vitamin K supports normal physiology and whether targeted supplementation can eventually be shown to improve meaningful cardiovascular outcomes in specific patients.

What Is Arterial Calcification?

Arterial calcification is the accumulation of calcium-containing mineral deposits within the walls of blood vessels.

It commonly develops with aging, atherosclerosis and certain chronic medical conditions.

However, not all arterial calcification occurs through the same process.

Intimal Calcification

Intimal calcification often develops within atherosclerotic plaques in the inner layer of the artery wall.

These plaques may contain cholesterol-rich material, inflammatory cells, fibrous tissue and varying amounts of calcium.

Medial Calcification

Medial calcification occurs within the muscular middle layer of the artery wall and is particularly relevant in diabetes, chronic kidney disease and certain other conditions.

It can contribute to arterial stiffness even without producing the same type of focal narrowing seen with atherosclerotic plaque.

Why the Distinction Matters

Coronary artery calcium scoring primarily identifies calcified coronary atherosclerosis, while other imaging techniques may reveal different patterns of vascular calcification.

Evidence involving one type of calcification should not automatically be applied to every vascular condition.

Is Calcium the Only Component of Arterial Plaque?

No. Atherosclerotic plaque includes lipids, inflammatory cells, fibrous tissue and other components.

Some plaques are heavily calcified, while others contain substantial noncalcified material.

The composition and behavior of plaque are important because the risk of a cardiovascular event depends on more than the amount of calcium alone.

How Does Calcium Build Up in Arteries?

Vascular calcification is a regulated biological process rather than simple passive accumulation of excess calcium from food.

Cells within blood vessel walls can undergo changes that promote mineral deposition, particularly in the presence of chronic vascular disease.

Inflammation and Atherosclerosis

Atherosclerosis begins with the retention of atherogenic lipoproteins within artery walls and involves inflammatory and tissue-repair responses.

As plaques develop and change, calcium may accumulate within them.

Vascular Smooth Muscle Cells

Under certain conditions, vascular smooth muscle cells can develop characteristics associated with mineral-forming cells.

This transformation is one mechanism studied in vascular calcification.

Calcium and Phosphorus Regulation

Calcium and phosphorus are essential minerals, but disturbances in their regulation can contribute to abnormal mineral deposition.

These processes are especially relevant in advanced kidney disease.

Diabetes and Metabolic Disease

Diabetes and insulin resistance are associated with vascular dysfunction and greater cardiovascular risk.

They may also influence calcification-related pathways.

Kidney Disease

Chronic kidney disease can disrupt mineral metabolism and is associated with accelerated vascular calcification.

However, vitamin K2 supplementation has not been established as a treatment that reliably reverses vascular calcification in kidney disease.

Why Calcium Intake Alone Is Not the Explanation

Arterial calcification should not be described as simply the result of consuming too much calcium.

Likewise, lowering dietary calcium indiscriminately is not an established method of removing coronary plaque.

What Is Vitamin K2?

Vitamin K2 refers to a group of fat-soluble compounds called menaquinones.

Vitamin K is required for the activation of several proteins involved in normal blood clotting, bone metabolism and other physiological processes.

What Are Menaquinones?

Menaquinones differ in the length of their chemical side chains and are identified by designations such as MK-4, MK-7 and MK-9.

What Is MK-7?

MK-7, or menaquinone-7, is a form commonly found in fermented foods such as natto and used in nutritional supplements.

It has a relatively long circulating half-life compared with some other vitamin K forms.

What Is MK-4?

MK-4 is another form of vitamin K2 that occurs in certain animal foods and can be produced in human tissues from other vitamin K compounds.

Is K2 an Essential Nutrient?

Vitamin K is essential, but official dietary reference intakes generally apply to total vitamin K rather than establishing a separate daily requirement for K2.

Why Is K2 Studied for Cardiovascular Health?

Researchers are investigating whether vitamin K2 can improve the activation of proteins involved in limiting inappropriate mineral deposition within vascular tissues.

That is a plausible research direction, but it does not establish that supplemental K2 removes existing arterial calcium.

What Is the Difference Between Vitamin K1 and K2?

Vitamin K1 and vitamin K2 belong to the same nutrient family but differ in chemical structure, food sources and some aspects of metabolism.

Vitamin K1 — Phylloquinone

Vitamin K1 is found primarily in green leafy vegetables such as spinach, kale and other greens.

It is an important dietary form of vitamin K and contributes to normal vitamin K-dependent protein activation.

Vitamin K2 — Menaquinones

Vitamin K2 compounds occur in certain fermented and animal-derived foods and are also available in supplements.

MK-7 is frequently used in studies investigating vascular calcification.

Is K2 Automatically Better for Arteries?

No. Different forms may have different absorption and distribution characteristics, but superiority in laboratory markers does not establish superiority in cardiovascular outcomes.

What Does Current Research Suggest?

Some trials of vitamin K1 and K2 have reported improvements in imaging measures of calcification progression, while others have not.

A 2026 review of vascular calcification research concluded that biochemical improvements in vitamin K status have not consistently translated into reductions in calcification progression or major cardiovascular events.

Can K1 and K2 Replace One Another Completely?

Both contribute to vitamin K physiology, but they differ in their food sources and metabolic characteristics.

There is no established clinical reason for everyone to replace dietary vitamin K1 from vegetables with concentrated K2 supplementation.

What Is Matrix Gla Protein?

Matrix Gla protein, abbreviated MGP, is a vitamin K-dependent protein found in vascular and other tissues.

It is considered an important regulator of mineral deposition.

Why Does MGP Matter?

Experimental research indicates that properly functioning MGP can help inhibit inappropriate calcium deposition within certain tissues.

How Does Vitamin K Activate MGP?

Vitamin K is required for a biochemical process called gamma-carboxylation.

This process modifies specific glutamate residues within vitamin K-dependent proteins, enabling them to perform normal functions.

What Happens When Vitamin K Is Inadequate?

Inadequate vitamin K availability can result in a greater proportion of undercarboxylated proteins.

Researchers have investigated whether this contributes to vascular calcification.

What Is dp-ucMGP?

Dephosphorylated-uncarboxylated matrix Gla protein, commonly abbreviated dp-ucMGP, is a circulating marker used in vitamin K research.

Higher concentrations are often interpreted as reflecting lower vitamin K-dependent MGP activation.

Does K2 Lower dp-ucMGP?

Many supplementation studies show that vitamin K2 can reduce circulating dp-ucMGP concentrations.

This demonstrates a biological effect on vitamin K-related protein status.

Does That Prove Existing Calcium Is Removed?

No. Improving a biochemical marker does not prove that established calcified plaque disappears.

Nor does it establish that the individual will experience fewer heart attacks, strokes or cardiovascular deaths.

Matrix Gla protein provides a plausible mechanism for studying vitamin K and vascular mineral regulation, but mechanism alone is not proof of clinical plaque reversal.

Does Vitamin K2 Move Calcium From Arteries Into Bones?

This is a popular description of vitamin K2, but it is not an accurate literal explanation of its biological function.

Vitamin K-dependent proteins participate in mineral regulation in different tissues.

However, calcium does not simply travel from an artery into bone because K2 is consumed.

Vitamin K and Bone Proteins

Vitamin K is required for the activation of osteocalcin, a protein involved in bone biology.

Vitamin K and Vascular Proteins

Matrix Gla protein participates in mechanisms involved in preventing inappropriate mineral deposition.

Are These Processes Connected?

They involve the same nutrient family and related biochemical reactions, but they occur through different tissue-specific systems.

Why the Popular Explanation Is Misleading

Saying that K2 sends calcium into bones and removes it from arteries suggests that supplementation has been proven to reverse calcified plaque.

Current clinical evidence does not support that conclusion.

What Can Be Said Accurately?

Vitamin K supports normal activation of vitamin K-dependent proteins involved in bone and vascular mineral physiology.

Researchers are investigating whether supplemental vitamin K can influence the development or progression of vascular calcification.

What Is a Coronary Artery Calcium Score?

A coronary artery calcium score, or CAC score, estimates the burden of calcified coronary atherosclerosis.

It is measured using a noncontrast cardiac CT scan.

What Is an Agatston Score?

The Agatston method combines information about the area and density of detected coronary calcium.

Results are reported in Agatston units, abbreviated AU.

What Does a Score of Zero Mean?

A CAC score of zero means no detectable coronary calcium was identified using the test.

This generally corresponds to lower short- to intermediate-term cardiovascular risk in selected asymptomatic adults.

However, it does not guarantee the absence of noncalcified plaque or eliminate the possibility of cardiovascular disease.

What Does a Higher Score Mean?

Higher CAC scores generally indicate a greater burden of calcified coronary atherosclerosis and are associated with higher cardiovascular risk.

What Counts as Severe Calcification?

The 2026 ACC/AHA dyslipidemia guideline categorizes CAC as absent at zero, minimal at 1–9 AU, mild at 10–99 AU, moderate at 100–299 AU, severe at 300–999 AU and extensive at 1,000 AU or higher.

Research trials may use different enrollment thresholds. For example, DANCODE enrolled people with scores of at least 400 AU.

Why Is CAC Testing Useful?

CAC scoring can help refine cardiovascular risk assessment in selected adults when preventive treatment decisions are uncertain.

It is not recommended as a universal screening test or as a repeated supplement-response test for everyone.

What Should Someone Do With a High Score?

A high CAC score should prompt appropriate cardiovascular risk evaluation and discussion of LDL-lowering treatment, blood-pressure control and other prevention measures.

Taking a supplement without addressing the underlying atherosclerotic risk would be an incomplete response.

Does a Lower Calcium Score Mean Less Plaque?

Not necessarily. Calcium is one component of coronary plaque, and changes in calcium scoring require careful interpretation.

Calcified and Noncalcified Plaque

Coronary plaques may include both calcified and noncalcified material.

A calcium scan does not fully measure every component of atherosclerosis.

Calcium Density and Plaque Stability

Some calcified plaque characteristics may be associated with greater plaque stability, while other patterns of calcification can occur in higher-risk lesions.

The relationship between calcification and plaque rupture is complex.

Why CAC May Increase During Effective Treatment

Statin treatment can contribute to changes in plaque composition, including greater calcification or calcium density, while reducing cardiovascular risk.

Therefore, increasing calcium on imaging is not automatically evidence that treatment is failing.

Does Slower Calcium Progression Guarantee Fewer Heart Attacks?

No. Although CAC is a useful risk marker, slowing its increase through a supplement has not yet been established as a reliable surrogate for preventing cardiovascular events.

What About Actual Plaque Volume?

Coronary CT angiography can provide additional information about calcified and noncalcified plaque.

Studies that evaluate both CAC scores and plaque composition may offer more context than calcium scores alone.

What Did the 2024 Vitamin K2 and D Trial Find?

A randomized clinical trial reported in 2024 investigated the effects of vitamin K2 combined with vitamin D on coronary artery calcium progression.

The analysis involved 304 men with a mean age of approximately 71 years and no prior ischemic heart disease.

What Was the Treatment?

Participants received vitamin K2 at 720 micrograms daily plus vitamin D at 25 micrograms, equivalent to 1,000 IU, or placebo.

How Long Did the Trial Last?

The intervention continued for two years.

What Happened to Calcium Scores?

Mean CAC scores increased by approximately 203 AU in the treatment group and 254 AU in the placebo group.

Although the treatment group had a smaller average increase, the difference across all participants did not reach conventional statistical significance.

What About People With Higher Baseline CAC?

Among participants whose initial CAC was at least 400 AU, progression was smaller with supplementation.

The mean increase was approximately 288 AU compared with 380 AU in the placebo group.

This subgroup difference was statistically significant in the reported analysis.

Did the Calcium Disappear?

No. Average CAC scores increased in both groups.

Did the Trial Prove Fewer Heart Attacks?

No. The trial was not sufficiently powered to establish reliable reductions in major cardiovascular events.

What Was the Main Conclusion?

The full analysis did not establish a statistically significant overall reduction in CAC progression, although the subgroup findings justified further investigation.

The trial was important because it helped motivate more focused research in patients with severe coronary calcification.

What Did the 2026 DANCODE Trial Find?

The DANCODE trial is among the most important recent studies of vitamin K2 and coronary calcification.

Published in Circulation in 2026, it specifically investigated patients with established severe coronary artery calcification.

Who Participated?

The trial randomized 400 participants with CAC scores of at least 400 Agatston units.

The main analysis included 398 participants, approximately 30% of whom were women.

The median age was 71 years, and the median baseline calcium score was 903 AU.

What Supplements Were Used?

The treatment group received vitamin K2 at 720 micrograms daily plus vitamin D3 at 25 micrograms, equivalent to 1,000 IU daily.

The control group received placebo.

How Long Were Participants Followed?

The intervention continued for 24 months, with cardiac CT scans performed at baseline, 12 months and 24 months.

What Happened to Coronary Calcium Scores?

The average CAC score increased by 196 AU in the vitamin K2 plus D3 group.

It increased by 248 AU in the placebo group.

The between-group difference was approximately 52 AU in favor of supplementation.

This difference was statistically significant.

How Large Was the Effect?

The treatment group experienced an approximately 21% smaller average increase in CAC score compared with placebo.

This represents slower progression, not a 21% reduction in the amount of calcium already present.

Did Any Calcium Disappear?

The average CAC scores increased in both groups.

Therefore, DANCODE did not demonstrate reversal of established calcification.

What Happened to Noncalcified Plaque?

A subset of 143 participants underwent coronary CT angiography.

The study found less progression of calcified plaque volume in the treatment group, while changes in noncalcified plaque volume did not differ significantly between groups.

This provides useful information about plaque composition, but it does not establish that the treatment reverses atherosclerosis.

Did DANCODE Prove Fewer Heart Attacks?

No. The trial's primary endpoint was the change in CAC score, not the occurrence of heart attacks, strokes or cardiovascular deaths.

The study was not designed to establish a definitive reduction in those clinical outcomes.

Can the Results Be Applied to Every K2 Supplement?

No. DANCODE used a specific combination of 720 micrograms of K2 and 1,000 IU of D3 daily.

Its results cannot automatically be applied to lower-dose K2 supplements, different formulations or products containing substantially higher vitamin D doses.

What Is the Appropriate Conclusion?

DANCODE supports the possibility that a specific K2/D3 regimen can slow coronary calcium progression in patients with severe calcification. It does not demonstrate calcium removal, plaque reversal or prevention of cardiovascular events.

What Did the 2026 VitaK-CAC Trial Find?

Another randomized clinical trial published in JAMA Cardiology in 2026 investigated menaquinone-7 supplementation in patients with symptomatic coronary artery disease.

Who Participated?

The trial included 180 adults with symptomatic coronary artery disease and CAC scores between 50 and 400 AU.

What Was the Treatment?

Participants received MK-7 at 360 micrograms daily or placebo.

How Long Did the Study Last?

The treatment period was two years.

What Was the Main Finding?

Participants receiving MK-7 experienced slower progression of coronary calcium scores compared with placebo.

Was Existing Calcium Removed?

No. The trial investigated progression of calcification, and the reported results do not establish that previously deposited calcium was eliminated.

Did MK-7 Prevent Heart Attacks?

The trial did not establish a reduction in major cardiovascular events.

The researchers emphasized the need for larger studies with clinical outcome endpoints.

Why Is This Study Important?

It adds evidence that vitamin K2 alone may influence calcium-score progression in some patients, rather than requiring the combination with vitamin D3 used in DANCODE.

However, the clinical significance of the imaging change remains uncertain.

Do the 2026 Studies Prove Vitamin K2 Works?

They provide meaningful new evidence for an effect on calcium-score progression in selected populations.

That is different from demonstrating a broadly effective cardiovascular treatment.

What Has Become More Convincing?

The hypothesis that vitamin K2 may influence calcification progression now has support from some randomized imaging studies.

What Is Still Unknown?

It remains uncertain whether these changes translate into fewer heart attacks, strokes, cardiovascular deaths or improved long-term survival.

Why Do Researchers Need Larger Trials?

Clinical cardiovascular events are relatively infrequent over short study periods.

Large trials with sufficient follow-up are needed to determine whether an intervention meaningfully changes those outcomes.

Do All Trials Agree?

No. Across different populations and conditions, vitamin K supplementation has produced inconsistent results.

A 2026 review focusing on vascular calcification emphasized that improvements in vitamin K-related biochemical markers have not consistently produced reproducible imaging or clinical benefits.

Should Guidelines Recommend K2 for Everyone With CAC?

Current evidence does not justify routine vitamin K2 supplementation as a standard treatment for coronary calcification.

Research findings should be interpreted alongside established cardiovascular prevention strategies rather than used to replace them.

Does Vitamin K2 Prevent Heart Attacks or Strokes?

Current evidence does not establish that vitamin K2 supplementation reliably prevents heart attacks or strokes.

Why Imaging Outcomes Are Not Enough

Coronary calcium scores are valuable for risk assessment, but changes in a biomarker or imaging measurement do not necessarily predict a treatment's effect on clinical events.

What About Observational Research?

Some observational studies have associated higher dietary menaquinone intake with lower cardiovascular risk.

However, these associations may be influenced by differences in food choices, lifestyle and other factors.

What Do Randomized Trials Show?

Selected studies have demonstrated slower calcium-score progression, but reliable reductions in major cardiovascular events have not yet been established.

Can K2 Replace Statins?

No. Statins and other indicated lipid-lowering medications have established clinical cardiovascular outcome benefits that are not reproduced by vitamin K2 supplementation.

What Should People With Coronary Disease Do?

Follow individualized treatment recommendations for LDL reduction, blood-pressure management, diabetes care, physical activity and other risk factors.

Vitamin K2 should not be used as a substitute for these measures.

Can Atherosclerotic Plaque Improve Without Removing Calcium?

Yes. The goal of atherosclerosis treatment is not simply to make all visible coronary calcium disappear.

Effective treatment can reduce cardiovascular risk through several mechanisms, including lowering atherogenic lipoprotein exposure and improving plaque stability.

LDL Reduction

Lowering LDL and other ApoB-containing particles reduces an important driver of atherosclerosis.

Changes in Plaque Composition

With appropriate treatment, some plaques may become more stable even when calcification remains or increases.

Reduced Cardiovascular Events

Major clinical trials have established reductions in heart attacks and other outcomes with appropriate LDL-lowering treatments.

Why Calcium Removal Is Not the Main Goal

A reduction in cardiovascular events is more important than achieving a lower calcium-score number without proven clinical benefit.

What About Established Plaque Regression?

Under selected circumstances, intensive cardiovascular risk management can stabilize and sometimes reduce aspects of atherosclerotic plaque burden.

This involves sustained treatment of LDL exposure and other contributors rather than a short-term artery cleanse.

Does Vitamin K2 Improve Arterial Elasticity?

Vitamin K2 has been investigated for possible effects on arterial stiffness and vascular elasticity.

Some trials have found favorable changes in selected vascular measurements, while others have reported limited or inconsistent effects.

What Is Arterial Stiffness?

Arterial stiffness describes reduced flexibility of blood vessels during the cardiac cycle.

It can be influenced by aging, blood pressure, vessel-wall composition and calcification.

Does Lower Stiffness Mean Plaque Reversal?

No. Arterial stiffness and atherosclerotic plaque burden are related but distinct measurements.

Does K2 Reliably Improve Blood Flow?

There is insufficient evidence that routine K2 supplementation reliably improves blood flow in people with coronary artery disease or peripheral artery disease.

Can K2 Open Blocked Arteries?

No. Vitamin K2 has not been established as a treatment that physically opens obstructed arteries.

Can Vitamin K2 Help With Calcification in Kidney Disease?

People with advanced chronic kidney disease often experience disturbances in calcium and phosphorus metabolism and may develop substantial vascular calcification.

This has made vitamin K supplementation an important research subject in nephrology.

Why Kidney Disease Changes Calcium Regulation

Kidney dysfunction can affect phosphate balance, vitamin D metabolism, parathyroid hormone regulation and vascular mineral deposition.

What About Matrix Gla Protein?

Vitamin K-dependent MGP activation remains biologically relevant in this population.

Have Supplements Reversed Calcification?

No consistent reversal has been demonstrated.

What Did the 2026 Review Conclude?

The 2026 review of vitamin K and vascular calcification in kidney disease found that vitamin K supplementation reliably changes certain biochemical markers but has not consistently improved CT-based calcification outcomes or demonstrated reductions in major cardiovascular events.

Should People With Kidney Disease Self-Supplement?

No. Mineral metabolism, medications and supplement safety require individualized nephrology guidance.

Is Vitamin K2 Necessary if You Take Vitamin D3?

Vitamin D and vitamin K have related roles in calcium physiology, but one does not automatically require high-dose supplementation with the other.

Vitamin D3 and Calcium Absorption

Vitamin D supports intestinal absorption of calcium and phosphorus.

Vitamin K2 and Protein Activation

Vitamin K participates in the activation of certain proteins involved in bone and vascular mineral physiology.

Does Every D3 Supplement Need K2?

No. Routine combined supplementation is not necessary for everyone.

Does K2 Prevent Vitamin D Toxicity?

No. Vitamin K2 should not be relied upon to prevent or treat hypercalcemia caused by excessive vitamin D intake.

Does D3/K2 Prevent Calcium From Entering Arteries?

That is not an established clinical effect of ordinary supplement use.

Why DANCODE Cannot Answer Every Combination Question

DANCODE tested a specific K2 and D3 regimen in people with severe existing coronary calcification.

It does not prove that every D3/K2 product is beneficial or that combining higher doses produces better results.

How Much Vitamin K Do Adults Need?

Official dietary reference values are based on total vitamin K intake, not a separately established requirement for vitamin K2.

Adult Men

The U.S. Adequate Intake for vitamin K is 120 micrograms daily.

Adult Women

The Adequate Intake is 90 micrograms daily.

What About Pregnancy and Lactation?

The adult Adequate Intake is generally 90 micrograms daily during pregnancy and breastfeeding.

Is There a Separate K2 Requirement?

No. Major U.S. dietary reference standards do not establish a specific daily requirement for MK-7 or another form of K2.

Does That Mean 180 Micrograms of K2 Is Necessary?

No. A supplement amount does not become a universal physiological requirement simply because it is used in a commercial formula or research trial.

What About 360 or 720 Micrograms?

These amounts were used in selected calcification trials. They should not be interpreted as recommended self-treatment doses for coronary disease.

Which Foods Provide Vitamin K?

Vitamin K can be obtained through a varied diet, including leafy vegetables, certain plant oils and some fermented or animal-derived foods.

Leafy Green Vegetables

Spinach, kale and other greens are useful sources of vitamin K1.

Natto

Natto, a fermented soybean food, is a concentrated dietary source of vitamin K2, particularly MK-7.

Other Fermented Foods

Certain cheeses and fermented foods contain menaquinones, although amounts vary widely.

Eggs and Animal Foods

Eggs, dairy and selected meats can contribute smaller quantities of vitamin K2.

Does Cooking Destroy Vitamin K?

Vitamin K is relatively stable under many ordinary cooking conditions, although food processing and preparation can affect nutrient content.

Does Dietary Fat Help Absorption?

Because vitamin K is fat-soluble, consuming vitamin K-containing foods with suitable dietary fat may improve absorption.

Should Everyone Eat Natto Daily?

No. Natto is one possible food source, but a heart-healthy diet does not require daily natto consumption.

People taking warfarin must pay particular attention to large or inconsistent changes in vitamin K intake.

Can You Have Too Little Vitamin K?

Clinically significant vitamin K deficiency is uncommon in generally healthy adults eating a varied diet.

However, some medical conditions increase the risk.

Malabsorption

Conditions that impair fat absorption can reduce vitamin K uptake.

Gastrointestinal Surgery

Certain surgeries affecting digestion or absorption may increase the risk of vitamin deficiencies.

Medication Effects

Some medications can interfere with vitamin K absorption or metabolism.

Deficiency Symptoms

Severe vitamin K deficiency can impair normal blood clotting and lead to bleeding-related problems.

Does Low Vitamin K Cause Coronary Plaque?

Low vitamin K status may influence biochemical pathways associated with vascular calcification, but it is not established as the sole or primary cause of coronary atherosclerosis.

Is Vitamin K2 Supplementation Safe?

Vitamin K2 has generally been well tolerated in many research studies, but safety depends on the dose, medical conditions and medications used.

Is There an Established Upper Intake Level?

The U.S. National Academies have not established a tolerable upper intake level for vitamin K because of insufficient evidence of toxicity at ordinary intakes.

Does That Mean Unlimited K2 Is Safe?

No. The absence of an established upper limit does not prove that unlimited doses are beneficial or appropriate.

Why Medication Interactions Matter

Vitamin K can substantially influence the effects of vitamin K antagonist medications such as warfarin.

What About D3/K2 Formulas?

Combination products also require evaluation of their vitamin D content.

A high-dose vitamin D3 component may create safety concerns even if vitamin K2 itself has a low toxicity potential.

What About Pregnancy or Chronic Illness?

Concentrated supplements should be assessed according to individual health circumstances rather than assumed universally suitable.

Why Is Vitamin K2 Important for People Taking Warfarin?

Warfarin reduces the activity of vitamin K-dependent clotting factors.

This effect is essential for its anticoagulant action in certain medical conditions.

How Does Vitamin K Affect Warfarin?

Changes in vitamin K intake can change warfarin's anticoagulant effect.

Can K2 Reduce Warfarin Effectiveness?

Yes. Increasing vitamin K intake may reduce anticoagulation and alter the international normalized ratio, or INR.

Why Is MK-7 Particularly Relevant?

MK-7 has a relatively long circulating half-life and can influence vitamin K-related biochemical pathways.

Even supplement amounts that seem modest may interfere with anticoagulation in susceptible people.

Should Warfarin Users Avoid All Leafy Greens?

No. They are generally advised to maintain a consistent vitamin K intake rather than eliminate nutritious vegetables.

Can Someone Start K2 While Taking Warfarin?

Not without guidance from the anticoagulation service or prescribing clinician.

Does the Same Rule Apply to Apixaban and Rivaroxaban?

Direct oral anticoagulants such as apixaban and rivaroxaban do not work by antagonizing vitamin K in the same way as warfarin.

However, all supplement use should still be reviewed in the context of the complete medication regimen and medical history.

Can K2 Replace Blood-Thinning Medication?

No. Vitamin K2 does not replace anticoagulant or antiplatelet treatment.

People taking warfarin should not begin, stop or substantially change vitamin K2 supplementation independently.

Does Vitamin K2 Interact With Other Medications?

Warfarin and related vitamin K antagonists are the most important interaction concern.

Other treatments can also affect vitamin K status or the safety of combined supplements.

Bile Acid Sequestrants

Medications such as cholestyramine can reduce absorption of fat-soluble vitamins, including vitamin K.

Orlistat

Orlistat reduces dietary fat absorption and may affect absorption of vitamin K and other fat-soluble nutrients.

Prolonged Antibiotic Use

Certain antibiotics and extended courses may influence vitamin K status, particularly when dietary intake is inadequate.

Thiazide Diuretics and Vitamin D

High-dose vitamin D within a D3/K2 formula may create hypercalcemia concerns when combined with certain medications such as thiazide diuretics.

Medication Review

Any decision to use a concentrated K2 or D3/K2 product should consider the complete formulation, not only the vitamin K amount.

What Does a High Calcium Score Mean for Treatment?

A high CAC score indicates a substantial burden of calcified coronary atherosclerosis and can influence preventive treatment decisions.

The goal is to reduce the likelihood of clinical cardiovascular events.

LDL Cholesterol

Reducing LDL and other ApoB-containing particles is central to slowing atherosclerotic disease and reducing risk.

Blood Pressure

Appropriate blood-pressure control reduces cardiovascular complications.

Diabetes

Managing blood sugar and associated metabolic risk can improve long-term cardiovascular outcomes.

Smoking

Smoking cessation is among the most important preventive actions.

Physical Activity

Regular activity supports cardiovascular fitness, blood-pressure regulation and metabolic health.

Individualized Medication

Statins and other appropriate LDL-lowering medications may be recommended according to the calcium score, clinical history and overall risk.

Why K2 Is Not a Replacement

Vitamin K2 supplementation has not demonstrated the same clinical cardiovascular outcome benefits as established preventive treatments.

Should Coronary Calcium Scans Be Repeated to Track K2 Supplements?

Not routinely. Coronary calcium scoring is most useful as a risk-assessment tool in selected patients.

It is not an established method of monitoring the benefit of vitamin K2 supplementation in ordinary clinical practice.

Why Repeating CAC Can Be Misleading

Calcium scores may increase even during effective lipid-lowering treatment.

The relationship between score changes and treatment benefit is not straightforward.

What About Radiation?

Coronary calcium CT involves a relatively small radiation exposure, but unnecessary repeated imaging should still be avoided.

What Matters More Than Repeating the Score?

LDL-C, ApoB when appropriate, blood pressure, diabetes control, smoking status, medication adherence and clinical symptoms often provide more actionable information.

When Might Imaging Be Needed?

Additional testing should follow clinical indications, including changes in symptoms or specific risk-assessment needs, rather than a desire to prove that a supplement is working.

Where Does Total Health Secrets Vitamin K2 Support Fit?

Total Health Secrets offers several verified nutritional products containing vitamin K2, primarily in combination with vitamin D3.

These formulas may be considered when there is an appropriate nutritional reason to supplement vitamin K or vitamin D.

However, the research discussed in this article does not establish that the finished Total Health Secrets products remove calcium from coronary arteries, reverse plaque or prevent heart attacks.

The distinction between product ingredient information and clinical outcome evidence is especially important because the published formulas contain doses different from those used in the major calcification trials.

Targeted Vitamin D3 and K2 Support — Premier Vitamin D3+K2

Premier Vitamin D3+K2 from Premier Research Labs is a plant-based combination supplement.

The current product listing identifies the following per capsule:

• Vitamin D3 — 125 micrograms, equivalent to 5,000 IU.
• Vitamin K2 — 180 micrograms as menaquinone, described as MK-7 in the product information.
• Vitamin E — 3.2 milligrams.
• Other ingredients — organic extra virgin olive oil and a vegetable capsule.

This formulation supplies two nutrients involved in calcium and mineral-related physiology.

However, it differs from the DANCODE treatment, which provided 720 micrograms of vitamin K2 with only 1,000 IU of vitamin D3 daily.

Therefore, DANCODE's calcium-score findings cannot be attributed to this commercial product.

The product page uses language suggesting that K2 directs calcium from the circulation into bones and offers strong cardiovascular protection. These descriptions should not be interpreted as clinical proof of existing coronary calcium removal.

The 5,000 IU vitamin D3 amount also exceeds the usual adult tolerable upper intake level of 4,000 IU daily.

Consequently, its full labeled serving should not be assumed appropriate as universal daily supplementation.

People taking warfarin should not begin this K2-containing product without medical guidance because of its potential effect on anticoagulation.

Vegan Combination Nutritional Support — Premier Vegan D3/K2

Premier Vegan D3/K2 — 60 Capsules is a second verified vitamin D3 and K2 formulation from Premier Research Labs.

The published supplement facts list:

• Vitamin D3 — 125 micrograms, equivalent to 5,000 IU, per capsule.
• Vitamin K2 — 180 micrograms as menaquinone, identified as MK-7 in the product description.
• Other ingredients — organic rice bran, organic rice concentrate, organic MCT oil extract and a plant-source capsule.

The product is designed for people seeking a vegan-compatible nutrient formulation.

Like Premier Vitamin D3+K2, it may serve a specific nutritional purpose when professionally appropriate.

However, the formula should not be marketed as proven to remove coronary calcium or prevent heart attacks.

It also provides 5,000 IU of vitamin D3 per capsule, exceeding the usual adult upper intake level.

Its vitamin K2 content requires medication review for people using warfarin or other vitamin K antagonists.

The product was listed as out of stock during the source review.

Broad Nutritional Support — Premier Multi-Vitamin

Premier Multi-Vitamin from Premier Research Labs is a broad multinutrient formula that includes vitamin K2 and vitamin D3.

The current product description identifies vitamin K2 as MK-7 and states an amount of 90 micrograms.

It also describes vitamin D3 as providing 1,300 IU.

However, the published supplement-facts information has shown conflicting vitamin D quantities, including a much higher amount in the supplement-facts section.

Because accurate dosage information is essential, the current physical manufacturer label should be verified before recommending a serving amount or combining this product with other D3/K2 supplements.

Premier Multi-Vitamin may be relevant to someone seeking broad nutritional support rather than a dedicated K2 product.

Nevertheless, its vitamin K content does not establish that the formula treats coronary calcification or improves cardiovascular events.

Warfarin users should review the vitamin K content with their prescribing clinician.

How Do THS Products Compare With DANCODE?

DANCODE used 720 micrograms of vitamin K2 and 1,000 IU of vitamin D3 daily.

The verified dedicated THS D3/K2 capsules provide 180 micrograms of K2 with 5,000 IU of vitamin D3 per capsule.

These formulas are not equivalent.

Taking multiple THS capsules to reach the DANCODE vitamin K2 amount would also greatly increase vitamin D3 intake and could create an unsafe exposure.

Readers should never attempt to reproduce the trial regimen by multiplying doses of a differently formulated commercial supplement.

Should D3/K2 Products Be Combined?

Not automatically.

Combining high-potency D3/K2 formulas with multivitamins or additional vitamin D may produce excessive total vitamin D intake.

It may also create significant changes in vitamin K exposure for people taking anticoagulants.

Which Product Should Someone Choose?

The appropriate choice depends on a defined nutritional need, existing dietary intake, medical conditions and medication safety.

There is no established basis for choosing a THS K2 product solely to dissolve coronary calcium.

Total Health Secrets K2-containing supplements may provide targeted nutritional support, but they should not replace evidence-based cardiovascular treatment or be presented as proven plaque-reversal therapies.

Explore the Heart, Blood Pressure, Cholesterol & Circulation collection for related nutritional-support options.

What Is the Best Food-First Approach to Arterial Health?

Arterial health depends on a broad pattern of nutrition and lifestyle habits rather than one vitamin.

The strongest evidence supports reducing exposure to the factors that drive atherosclerosis and other cardiovascular disease.

Improve Dietary Fat Quality

Replace excess saturated fat with suitable unsaturated fats from foods such as olive oil, nuts and seeds.

Increase Viscous Soluble Fiber

Oats, barley and psyllium can modestly lower LDL cholesterol.

Eat More Legumes and Vegetables

Beans, lentils, vegetables and other plant foods support dietary fiber and overall nutrient intake.

Include Suitable Protein Sources

Fish, legumes, low-fat dairy and lean unprocessed poultry can fit into a heart-healthy eating pattern.

Maintain Adequate Vitamin K

Leafy greens and other foods can contribute vitamin K without requiring concentrated K2 supplementation.

Support Vitamin D Adequacy

Appropriate food sources, fortified foods and supplements when necessary can help maintain normal vitamin D status.

Manage Sodium

Reducing excess sodium supports blood-pressure control.

Maintain Appropriate Physical Activity

Regular aerobic and resistance exercise supports cardiovascular fitness, blood-pressure regulation and metabolic health.

Address Smoking and Diabetes

Smoking cessation and appropriate glucose management are important components of cardiovascular prevention.

This combined approach has stronger established clinical outcome evidence than using K2 as an artery-cleansing strategy.

A Practical 14-Step Strategy for Coronary Calcium and Vascular Health

Step 1 — Understand What Arterial Calcification Means

Recognize calcification as one component of vascular disease rather than simply an accumulation of excess dietary calcium.

Step 2 — Review Your Cardiovascular Risk

Consider LDL, ApoB when appropriate, blood pressure, diabetes, smoking, family history and established cardiovascular disease.

Step 3 — Interpret CAC Results Correctly

Use coronary calcium scoring as a risk-assessment tool when indicated rather than a direct measure of supplement effectiveness.

Step 4 — Address LDL Exposure

Improve saturated-fat intake, increase appropriate fiber and use prescribed lipid-lowering treatment when indicated.

Step 5 — Maintain Blood-Pressure Control

Use DASH-style nutrition, suitable activity and medication when necessary.

Step 6 — Manage Glucose and Metabolic Health

Address diabetes, insulin resistance and other relevant metabolic conditions.

Step 7 — Avoid Smoking

Stopping smoking reduces cardiovascular risk.

Step 8 — Maintain Appropriate Movement

Build regular aerobic activity and resistance training according to health and physical capacity.

Step 9 — Obtain Vitamin K Through Food

Include suitable leafy greens and other vitamin K-containing foods in a varied diet.

Step 10 — Maintain Vitamin D Adequacy

Address documented inadequacy without assuming high-dose supplementation prevents arterial calcification.

Step 11 — Review Warfarin and Other Medications

Do not begin K2 supplementation independently when taking vitamin K antagonists.

Step 12 — Check Supplement Labels

Review total vitamin K and D amounts, including overlapping multivitamin or combination products.

Step 13 — Do Not Confuse Research Doses With Recommendations

Clinical trial quantities do not establish appropriate self-treatment regimens for ordinary commercial products.

Step 14 — Prioritize Meaningful Outcomes

Measure progress through established cardiovascular risk management and clinical follow-up rather than expecting visible calcium deposits to disappear.

When Should Coronary Calcification Receive Medical Attention?

A high coronary calcium score deserves appropriate cardiovascular risk assessment, even when the person has no symptoms.

Known High CAC

Discuss the implications of the result with a clinician, including LDL-lowering treatment and other preventive measures.

Chest Discomfort

New exertional chest discomfort or reduced exercise tolerance warrants medical evaluation.

Possible Heart Attack

Severe or persistent chest pain, particularly with breathlessness, sweating, nausea or fainting, requires emergency care.

Possible Stroke

Sudden weakness, facial drooping, difficulty speaking or other acute neurological symptoms require emergency assessment.

Known Kidney Disease

People with kidney disease and vascular calcification may require specialized evaluation of mineral metabolism.

Do Not Use K2 as Emergency Treatment

Vitamin K2 supplements are not treatments for acute coronary syndromes, stroke or severe vascular obstruction.

Frequently Asked Questions About Vitamin K2 and Arterial Calcium

Does vitamin K2 remove calcium from arteries?

No. Current evidence does not establish that vitamin K2 removes existing arterial calcium deposits.

Can vitamin K2 reverse coronary calcification?

No reliable clinical evidence demonstrates reversal of established coronary calcification through K2 supplementation.

Can K2 slow calcium buildup?

Some recent randomized trials suggest slower coronary calcium-score progression in selected patients, but results are not yet sufficient for universal treatment recommendations.

What did the DANCODE trial find?

The 2026 trial found slower progression of severe coronary calcium scores with 720 micrograms of K2 plus 1,000 IU of D3 daily over 24 months.

Did DANCODE remove calcium?

No. Average calcium scores increased in both the treatment and placebo groups.

How much slower was calcification in DANCODE?

The average score increase was 196 AU with supplementation versus 248 AU with placebo, a difference of 52 AU over two years.

Did DANCODE prevent heart attacks?

No. The trial primarily measured changes in coronary calcium scores, not reductions in heart attacks or cardiovascular deaths.

What did the 2024 K2/D trial show?

The full analysis did not demonstrate a statistically significant calcium-score benefit, but a subgroup with higher baseline calcification showed slower progression.

What is the VitaK-CAC trial?

It is a 2026 randomized study reporting slower coronary calcium-score progression with MK-7 in selected patients with symptomatic coronary disease.

Did VitaK-CAC prove K2 prevents cardiovascular disease?

No. It evaluated imaging changes and did not establish reductions in major cardiovascular events.

What is matrix Gla protein?

Matrix Gla protein is a vitamin K-dependent protein involved in regulating mineral deposition within vascular and other tissues.

How does vitamin K activate MGP?

Vitamin K is required for a biochemical modification called gamma-carboxylation that enables normal protein function.

What is dp-ucMGP?

It is a circulating marker used in research to assess aspects of vitamin K-dependent MGP activation.

Does lowering dp-ucMGP remove plaque?

No. Improving a biochemical marker does not demonstrate removal of existing atherosclerotic plaque.

Does K2 send calcium into bones?

Vitamin K participates in protein functions relevant to bone metabolism, but the popular description of physically redirecting arterial calcium into bones oversimplifies the biology.

What is the difference between K1 and K2?

K1 is phylloquinone, found mainly in leafy greens. K2 consists of menaquinones found in certain fermented and animal-derived foods.

What is MK-7?

MK-7 is menaquinone-7, a form of vitamin K2 often used in supplements and vascular calcification studies.

Is MK-7 better than MK-4 for arteries?

No reliable clinical evidence establishes universal superiority for preventing cardiovascular events or reversing calcification.

How much K2 should adults take?

There is no separate universally established daily requirement for K2. U.S. adequate intakes apply to total vitamin K.

Is 180 micrograms of K2 enough?

It is a dose found in some commercial supplements, but no evidence establishes it as a guaranteed treatment for coronary calcification.

Should I take 720 micrograms of K2 like DANCODE?

Not independently. The research dose does not establish a universal recommendation, and trial findings cannot automatically be applied to other formulations.

Does D3 make K2 more effective?

Both vitamins participate in calcium-related physiology, but the best combination and its clinical benefits are not established for general cardiovascular prevention.

Does K2 prevent vitamin D toxicity?

No. Vitamin K2 does not reliably prevent hypercalcemia or other complications from excessive vitamin D intake.

Do I need K2 every time I take vitamin D?

No. Combined supplementation is not universally necessary.

Can K2 reverse a high CAC score?

No. Current trials suggest possible slowing of progression in selected patients, not elimination of existing calcium.

What does a CAC score of zero mean?

It indicates no detectable calcified coronary plaque on the test but does not exclude all noncalcified plaque or cardiovascular risk.

What does a CAC score of 400 mean?

It indicates a substantial burden of calcified coronary atherosclerosis and usually warrants careful cardiovascular risk management.

Can a calcium score increase even when treatment is working?

Yes. Calcification may increase or become denser during effective plaque-stabilizing treatment, including statin therapy.

Does a lower calcium-score increase guarantee fewer heart attacks?

No. Clinical outcomes must be demonstrated independently.

Can vitamin K2 unclog blocked arteries?

No. It has not been established as a treatment that reopens narrowed or blocked coronary arteries.

Can K2 prevent stroke?

There is insufficient evidence that routine K2 supplementation prevents stroke.

Does K2 lower LDL cholesterol?

Vitamin K2 is not an established LDL-lowering treatment.

Does K2 lower blood pressure?

It has not demonstrated a sufficiently reliable effect to replace established blood-pressure management.

Can K2 improve circulation?

Its role in vascular mineral-related pathways is under investigation, but supplementation is not a proven treatment for impaired circulation.

Is natto a good source of K2?

Yes. Natto is particularly rich in MK-7, though its high vitamin K content requires attention for warfarin users.

Are leafy greens enough for vitamin K?

A varied diet containing leafy greens and other appropriate foods can generally provide adequate total vitamin K for most healthy adults.

Does K2 interact with warfarin?

Yes. K2 can alter warfarin's anticoagulant action and INR control.

Does K2 interact with apixaban?

Apixaban does not work through vitamin K antagonism, but supplements should still be reviewed with the healthcare professional managing anticoagulation.

Can people with kidney disease take K2?

Supplementation should be individualized because kidney disease can involve complex mineral metabolism and medication concerns.

Is Premier Vitamin D3+K2 proven to remove calcium?

No. The product provides vitamin D3 and K2 but has not been clinically established as a coronary calcium-removal treatment.

How much K2 is in Premier Vegan D3/K2?

The verified formulation provides 180 micrograms of K2 per capsule, along with 5,000 IU of vitamin D3.

Can I take four D3/K2 capsules to match the DANCODE K2 dose?

No. Four capsules of the verified THS formulation would also provide 20,000 IU of vitamin D3, far above the usual adult upper intake level and much more vitamin D than used in DANCODE.

Should K2 replace statins?

No. Statins have established cardiovascular outcome benefits when indicated; K2 does not have comparable evidence.

What should I do if I have a high coronary calcium score?

Discuss cardiovascular risk, LDL management, blood pressure, diabetes, smoking and appropriate treatment with your clinician rather than relying on supplements to remove plaque.

A Better Definition of Vitamin K2 and Arterial Health Support

Vitamin K2 is an important part of normal physiology, but its relationship with arterial calcification is more complex than the idea of moving calcium from arteries into bones.

Vitamin K participates in the activation of proteins such as matrix Gla protein, which are involved in mineral regulation within vascular tissues.

This biological role provides a legitimate reason for investigating whether K2 can influence the development of vascular calcification.

Recent randomized trials have strengthened the evidence that selected vitamin K2 regimens may slow the progression of coronary calcium scores in certain patients.

The 2026 DANCODE trial is particularly important because it demonstrated a statistically significant reduction in calcium-score progression among people with severe existing coronary calcification.

However, calcium scores increased in both groups, meaning the study did not demonstrate removal of existing deposits.

The newer VitaK-CAC trial also reported slower progression with MK-7, but its imaging findings do not establish fewer heart attacks or improved survival.

The difference between a biochemical mechanism, an imaging outcome and a clinical health outcome remains essential.

Vitamin K2 may influence certain pathways involved in vascular mineral deposition, but that is not yet the same as proving that supplementation prevents cardiovascular disease.

Nor does it justify replacing established treatments for LDL cholesterol, hypertension, diabetes or coronary atherosclerosis.

Food-first nutrition remains the most practical foundation for long-term heart health. A varied diet can provide vitamin K through leafy vegetables and other foods while supporting fiber intake, healthy fats and broader cardiovascular nutrition.

Targeted K2-containing supplements may serve defined nutritional purposes, but product doses, vitamin D content and medication interactions must be considered carefully.

This is especially important for people taking warfarin and for those considering high-potency D3/K2 combinations.

Total Health Secrets offers verified K2-containing products, but their finished formulations have not demonstrated coronary calcium removal or prevention of heart attacks.

The most meaningful cardiovascular strategy remains sustained control of LDL exposure, blood pressure, blood sugar, smoking and other established risk factors.

A better definition of vitamin K2 and arterial health support is maintaining adequate vitamin K for normal protein and mineral physiology while recognizing promising calcification research without mistaking slower calcium-score progression for established plaque reversal or cardiovascular-event prevention.

For a broader understanding of arterial plaque, coronary calcium, cholesterol and cardiovascular prevention, continue reading our pillar guide: Heart Health Explained: Blood Pressure, Cholesterol, Circulation and Cardiovascular Risk.

References and Further Reading

1. Hasific S, Øvrehus KA, Mejldal A, et al. Vitamin K2 and D3 Supplementation in Patients With Severe Coronary Artery Calcification: The DANCODE Trial. Circulation. 2026. Randomized trial evaluating progression of severe coronary calcification over 24 months.
2. Effects of Vitamin K2 and D Supplementation on Coronary Artery Disease in Men: A Randomized Controlled Trial. JACC: Advances. 2024. Main and subgroup analyses of coronary calcium progression.
3. Effects of Vitamin K2 and D Supplementation on Coronary Artery Disease in Men — Full Text. Reports the primary results and higher-CAC subgroup findings.
4. Vossen LM, de Leeuw PW, Schurgers LJ, et al. Two Years of Menaquinone-7 Supplementation and Coronary Artery Calcification: A Randomized Clinical Trial. JAMA Cardiology. 2026. VitaK-CAC trial.
5. Vitamin K and Vascular Calcification: From Biological Plausibility to Clinical Realism. Clinical Kidney Journal. 2026. Review of vitamin K, matrix Gla protein and clinical outcomes.
6. National Institutes of Health Office of Dietary Supplements. Vitamin K: Fact Sheet for Health Professionals. Current guidance on vitamin K forms, recommended intake, MGP, vascular calcification and warfarin interactions.
7. National Institutes of Health Office of Dietary Supplements. Vitamin D: Fact Sheet for Health Professionals. Vitamin D intake, calcium physiology, upper intake limits and safety.
8. American College of Cardiology and American Heart Association. 2026 Guideline on the Management of Dyslipidemia. Current recommendations for LDL management and coronary calcium-based cardiovascular risk assessment.
9. 2026 ACC/AHA Multisociety Dyslipidemia Guideline — Full Text. Includes coronary calcium risk categories and preventive treatment guidance.
10. American Heart Association. 2025 High Blood Pressure Guideline. Blood-pressure risk assessment and treatment recommendations.
11. American Heart Association. Life's Essential 8. Food, activity, smoking avoidance, cholesterol, blood pressure and metabolic-health priorities.
12. National Heart, Lung, and Blood Institute. DASH Eating Plan. Food-first dietary approaches to cardiovascular health.
13. Total Health Secrets. Premier Vitamin D3+K2. Published 5,000 IU vitamin D3 and 180-microgram K2 formulation.
14. Total Health Secrets. Premier Vegan D3/K2 — 60 Capsules. Published plant-based vitamin D3 and K2 ingredients.
15. Total Health Secrets. Premier Multi-Vitamin. Published multinutrient formulation containing K2; vitamin D labeling should be reconciled before dosage recommendations.

Educational Disclaimer: This article provides general educational information and does not replace individualized medical advice, diagnosis or treatment. Vitamin K2 is important for normal physiology, but it has not been established as a treatment that removes existing arterial calcium, reverses coronary atherosclerosis or prevents major cardiovascular events. Some recent randomized trials report slower coronary calcium-score progression with specific vitamin K2 or vitamin K2/D3 regimens in selected patients; these findings should not be generalized to all supplement products or interpreted as proof of fewer heart attacks or strokes. Coronary calcium scores are markers of atherosclerotic burden and should be interpreted in clinical context. Vitamin K2 can interfere with warfarin and other vitamin K antagonist medications and should not be started or stopped independently by people using these drugs. Products combining K2 with high-dose vitamin D3 may exceed established vitamin D upper intake limits and require individualized assessment. People with kidney disease, calcium metabolism disorders, significant cardiovascular conditions or complex medication regimens should seek professional guidance before concentrated supplementation. Do not discontinue prescribed statins, blood-pressure medication or anticoagulants in favor of nutritional supplements. Seek emergency care for possible heart attack or stroke symptoms.